Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
CoreMap logo — You have to 'see' AF to treat AF.

CoreMap

You have to 'see' AF to treat AF.

Founded 2016 United States Burlington, United States 39 employees Series B Total: $33.75M Biotechnology, Health Care +1

General Information

Company Name CoreMap
Founded Year 2016
Location United States Burlington, United States
Founders / Decision Makers
Team member
Employees 39
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with CoreMap. To contact CoreMap, visit coremapmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CoreMap compare?

A PDF of CoreMap and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CoreMap soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CoreMap

CoreMap is a biotechnology and health care startup that is focused on improving patient outcomes by providing advanced diagnostic technology to electrophysiologists and patients. The company's slogan, "You have to 'see' AF to treat AF," underscores their commitment to developing patient-specific treatments for the 33 million individuals suffering from atrial fibrillation. This approach recognizes that a one-size-fits-all solution does not suffice for such a diverse patient population. Having been established in 2016 and headquartered in the United States, CoreMap recently secured a significant $3.00M Series A investment on 09 February 2022. The company's expansion is further evident in their active recruitment efforts across various departments, as they seek talented individuals to contribute to their mission. Furthermore, for those interested in career opportunities with CoreMap, they can explore current job openings by contacting [email protected]. As a venture capital analyst, it is notable that CoreMap's recent funding round signifies investor confidence in the company's vision and technological advancements. This injection of capital is critical as the startup progresses in its mission to revolutionize cardiac care. Moreover, the emphasis on tailored treatments and the potential to address a substantial patient population make CoreMap an intriguing prospect for those seeking investment opportunities in the ever-evolving health tech sector.

Business keywords: Medical Device, Cardiac mapping, Electrophysiology, Cardiology, Innovation, Atrial fibrillation, Arrhythmia, Medtech

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $20.00M 3
Qure Ventures
Qure Ventures, Russ Scully +1
09 Feb 2022
Series A $3.00M -
09 Feb 2022
Series A $10.50M 2
Qure Ventures
Qure Ventures, Ron Ginor
16 Sep 2020
Grant $251.13K 1
National Science Foundation
National Science Foundation
26 Aug 2020

CoreMap Alternatives & Competitors

View All Alternatives
CoreMap vs
Volta Medical
Volta Medical France

Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysio...

Series B
116 employees
AI, Health Care
Compare CoreMap vs Volta Medical
CoreMap vs
Biosense Webster
Biosense Webster United States

Discover a New Possible

3404 employees
Biotechnology, Health Care
Compare CoreMap vs Biosense Webster
CoreMap vs
Acutus Medical, Inc.
Acutus Medical, Inc. United States

Leading The Charge™️

Post-IPO Debt
87 employees
Biotechnology, Health Care
Compare CoreMap vs Acutus Medical, Inc.
Also compare with: CoreMap vs AtaCor Medical, Inc. AtaCor Medical, Inc. View all alternatives

FAQ About CoreMap

You have to 'see' AF to treat AF.
CoreMap was founded in 2016.
CoreMap is headquartered in Burlington, United States.
CoreMap operates in Biotechnology, Health Care and Medical Devices. Its work centres on Medical Device, Cardiac mapping, Electrophysiology and Cardiology.
CoreMap has approximately 39 employees.
CoreMap has completed 4 funding rounds, raising a total of $33.75M. The latest funding stage is Series B.
Top alternatives and competitors to CoreMap include Volta Medical, Biosense Webster, Acutus Medical, Inc., CardioFocus, SIMPLEX QUANTUM, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CoreMap and Volta Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CoreMap, https://bouncewatch.com/company/coremap, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout